Skip to main content
Equibles

BARCLAYS PLC

Position in LYEL — Lyell Immunopharma, Inc.

CIK 312069 LONDON, X0
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$66,244
+$32,724 QoQ
Shares Held
4,715
+182.2% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 87 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. LYEL ranks #266 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in LYEL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $66,244 4,715
2026-03-31 $33,520 1,671
2025-12-31 $491,464 15,967
2025-09-30 $19,358 1,192
2025-06-30 $10,210 1,155
2025-03-31 $98,705 183,467
2024-12-31 $165,363 258,380
2024-09-30 $332,047 240,615
2024-06-30 $84,535 58,300
2024-03-31 $326,786 146,541
2023-12-31 $510,355 263,070
2023-09-30 $360,507 245,243
2023-06-30 $630,492 198,268
2023-03-31 $578,791 245,251
2022-12-31 $1,163,865 335,408
2022-09-30 $987,409 134,708
2022-06-30 $56,619 8,684
2022-03-31 $164,826 32,639